Detail page

Knowledge Web

Person

Selim Corbacioglu (1964-)

Name	Selim Corbacioglu
Time	1964- (Date of birth and death)
Place	Viechtach (Geburtsort)
Academic degree	Dr. med.
Further information	Habil. Fachgebiet Kinderheilkunde an der Univ. Ulm
Record type	Person
GND-Identifier	113722451
Record ID	113722451
Involved in show all Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression Chemo-Immuntherapie mit anti-GD2 Antikörper Dinutuximab beta bei Kindern mit einem Rückfall oder einem refraktären Hochrisikoneuroblastom Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Specialized pediatric palliative care services in pediatric hematopoietic stem cell transplant centers Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections - a report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Correction: ABO incompatibile graft management in pediatric transplantation Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations Sickle cell disease in Germany: results from a national registry Sickle cell disease in Germany: Results from a national registry Childhood supratentorial ependymomas with YAP1-MAMLD1<br> fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) Stammzellfaktor und Stammzellfaktorrezeptor c-kit : Pathomechanismen, humanpathogenetische Relevanz und molekulare Therapieansätze Untersuchung zur angiogenetischen Wirkung des Granulozyten Kolonien-stimulierenden Faktors (G-CSF) in vivo an einem Xenotransplantationsmodell der humanen Glioblastomzellinie U-87 MG

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Selim Corbacioglu (1964-)

Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP

Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

Chemo-Immuntherapie mit anti-GD2 Antikörper Dinutuximab beta bei Kindern mit einem Rückfall oder einem refraktären Hochrisikoneuroblastom

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies

Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trial

Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major

Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation

GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation

Specialized pediatric palliative care services in pediatric hematopoietic stem cell transplant centers

Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections - a report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Correction: ABO incompatibile graft management in pediatric transplantation

Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations

Sickle cell disease in Germany: results from a national registry

Sickle cell disease in Germany: Results from a national registry

Childhood supratentorial ependymomas with YAP1-MAMLD1<br> fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Stammzellfaktor und Stammzellfaktorrezeptor c-kit : Pathomechanismen, humanpathogenetische Relevanz und molekulare Therapieansätze

Untersuchung zur angiogenetischen Wirkung des Granulozyten Kolonien-stimulierenden Faktors (G-CSF) in vivo an einem Xenotransplantationsmodell der humanen Glioblastomzellinie U-87 MG